Drug Development And Market PotentialAnalyst recommends considering ALKS2680's potential to revolutionize narcolepsy treatment, given its early positive efficacy data and a clear dose response, suggesting a strong market contender.
Financial GrowthIncreasing sales of Lybalvi and a significant growth in the number of prescribers are key indicators of the drug's expanding market presence, pointing towards a bullish outlook for revenue growth.
Strategic PartnershipsAlkermes' recent deal with a large national PBM to improve commercial access for Lybalvi exemplifies strategic partnerships that can serve as a major catalyst for market penetration and stock performance.